Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

CNS & Neurological Disorders - Drug Targets , Volume 12 - Number 6






Screening for Inhibitors of Microglia to Reduce Neuroinflammation

, 12(6): 741 - 749

Shazia Samanani, Manoj Mishra, Claudia Silva, Brooke Verhaeghe, Janet Wang, Jade Tong and V. Wee Yong


DOI: 10.2174/18715273113126660177












Alteration of Isocitrate Dehydrogenase Following Acute Ischemic Injury as a Means to Improve Cellular Energetic Status in Neuroadaptation

, 12(6): 849 - 860

Kimberly N. Grelli, Amy M. Palubinsky, A. Cozette Kale, Britney N. Lizama-Manibusan, Jeannette N. Stankowski, Ginger L. Milne, Robert Singer and BethAnn McLaughlin


DOI: 10.2174/18715273113129990062






Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog